MedTrace Logo

Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian Adults

NCT01517191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4197

Last updated 2018-03-30

No results posted yet for this study

Summary

This surveillance study will include all consenting adults hospitalized with influenza (cases) at the SOS network of hospitals as well as influenza negative patients(controls), to assess vaccine effectiveness in each group. Both groups will be followed throughout their hospitalization and for 30 days post discharge to monitor severity of illness and outcomes following their illness.

Conditions

Sponsors & Collaborators

  • Public Health Agency of Canada (PHAC)

    collaborator OTHER_GOV

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Dalhousie University

    lead OTHER

Principal Investigators

  • Shelly A McNeil, MD · Dalhousie University

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01517191 on ClinicalTrials.gov